All fields are required.

Close Appointment form

Over 30.000 People will Fight Cancer in Ecuador by 2020

  • Home
  • Over 30.000 People will Fight Cancer in Ecuador by 2020
Over 30.000 People will Fight Cancer in Ecuador by 2020
Over 30.000 People will Fight Cancer in Ecuador by 2020

No Comments

Over 30.000 People will Fight Cancer in Ecuador by 2020

According to the National Agreement against Cancer Ecuador, more health policies should be developed to prevent this issue.

cancer ecuador

The National Agreement Network against Cancer estimates that by the next three years the numbers of deaths by cancer would be of 20,000 in Ecuador.

Wilson Merino Rivadeneira, Coordinator at the Oncology Patients Network Organization, the number of deaths would be reduced if actions are taken to fight the disease.

“Patients don’t only struggle against cancer, the fight against poverty, injustice, intolerance and discrimination”, says Merino in an interview with the newspaper El Telégrafo.

What kind of cancer are killing Ecuadorian?

While cancer research in Ecuador is still scarce, there is a consensus about the types of cancer that cause the most mortality.

In children, the most common is acute childhood lymphoblastic leukemia (ALL), a type of cancer in which the bone marrow produces too many immature lymphocytes (a type of white blood cell). So leukemia can affect red blood cells, white blood cells and platelets.

In Ecuadorian women is breast cancer. In fact, according to the American Cancer Society (ACS), it will kill 5.5 million women a year globally by 2030. This alarming number is attributed to the increase in known cancer risk factors associated with Physical inactivity, poor diet, obesity and reproductive causes, such as having a first child at an advanced age, which could increase the risks of breast cancer.

In the male population, prostate cancer is the most common and whenever it is detected in localized phases (i.e. within this sex gland and not yet disseminated), the possibility of cure can exceed 90%.

Wilson Merino warns that, today, one in two Ecuadorians has a close family member who suffers from cancer, revealing that it is not a disease of others. He explains that one of the purposes of the network is to promote more research on the subject.

The Ecuadorian oncologist, Tania Soria, assures that the National Cancer Registry managed by SOLCA is internationally recognized and has even won several awards. “In SOLCA there is a National Registry, where not only the data are collected from this health home, but also from private and public entities. It is a fairly large and real sampling of each city.”

Soria points out that the last bulletin on tumors was published the previous year. “It seems to me that there is a lot of knowledge in the country about the pathology of cancer. We also have a casuistic (set of cases) quite close, but not everyone knows how to access that data.”

OTHER DATA

  • More than 60% of the new cancer cases in the world take place in Africa, Asia, South America and Central America.
  • An estimated 11.5 million people die from cancer by 2030, the World Health Organization (WHO) reported.
  • The types of cancer that cause the greatest number of annual deaths in the world are lung, followed by those of stomach, liver, colon, breast, cervical and prostate.

THE CHALLENGE IS TO BOOST PRECISION MEDICINE

Scientists call it precision medicine and could revolutionize Existing treatments to combat this disease, because it is possible to identify the most appropriate treatment for each patient, according to the molecular classification that the disease has.

In this way, it is possible to reduce the adverse effects that can impact the quality of life of the people. Precision medicine as a treatment is a method used in diseases such as breast and lung cancer. It is also important to note that these advances may benefit patients with liver, colon and stomach cancer, among others.

In addition, contrary to chemotherapy treatments and radiotherapy, specific or precision medicine allows healthy cells to be preserved, which is already an important advance for medicine.

Interested in Clinical Trials in Latin America?

DOWNLOAD OUR FREE WHITE PAPER

 

  • Share This

Related Posts

Submit a comment

Your email address will not be published. Required fields are marked *

Leave a Reply

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

%d bloggers like this: